<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Milgrom ZZ</submitter><funding>U.S. National Library of Medicine</funding><funding>Lilly Endowment</funding><pagination>2883-2894</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9904246</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Measures taken to address the COVID-19 pandemic interrupted routine diagnosis and care for breast cancer. The aim of this study was to characterize the effects of the pandemic on breast cancer care in a statewide cohort.&lt;h4>Patients and methods&lt;/h4>Using data from a large health information exchange, we retrospectively analyzed the timing of breast cancer screening, and identified a cohort of newly diagnosed patients with any stage of breast cancer to further access the information available about their surgical treatments. We compared data for four subgroups: pre-lockdown (preLD) 25 March to 16 June 2019; lockdown (LD) 23 March to 3 May 2020; reopening (RO) 4 May to 14 June 2020; and post-lockdown (postLD) 22 March to 13 June 2021.&lt;h4>Results&lt;/h4>During LD and RO, scree</pubmed_abstract><journal>Annals of surgical oncology</journal><pubmed_title>Breast Cancer Screening, Diagnosis, and Surgery during the Pre- and Peri-pandemic: Experience of Patients in a Statewide Health Information Exchange.</pubmed_title><pmcid>PMC9904246</pmcid><funding_grant_id>LILLY END/20091568000</funding_grant_id><funding_grant_id>T15LM012502</funding_grant_id><pubmed_authors>Hui SL</pubmed_authors><pubmed_authors>Fisher CS</pubmed_authors><pubmed_authors>Milgrom DP</pubmed_authors><pubmed_authors>Haggstrom DA</pubmed_authors><pubmed_authors>Milgrom ZZ</pubmed_authors><pubmed_authors>Mendonca EA</pubmed_authors><pubmed_authors>Han Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Breast Cancer Screening, Diagnosis, and Surgery during the Pre- and Peri-pandemic: Experience of Patients in a Statewide Health Information Exchange.</name><description>&lt;h4>Background&lt;/h4>Measures taken to address the COVID-19 pandemic interrupted routine diagnosis and care for breast cancer. The aim of this study was to characterize the effects of the pandemic on breast cancer care in a statewide cohort.&lt;h4>Patients and methods&lt;/h4>Using data from a large health information exchange, we retrospectively analyzed the timing of breast cancer screening, and identified a cohort of newly diagnosed patients with any stage of breast cancer to further access the information available about their surgical treatments. We compared data for four subgroups: pre-lockdown (preLD) 25 March to 16 June 2019; lockdown (LD) 23 March to 3 May 2020; reopening (RO) 4 May to 14 June 2020; and post-lockdown (postLD) 22 March to 13 June 2021.&lt;h4>Results&lt;/h4>During LD and RO, scree</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-25T18:30:18.244Z</modification><creation>2025-04-06T07:34:05.472Z</creation></dates><accession>S-EPMC9904246</accession><cross_references><pubmed>36749504</pubmed><doi>10.1245/s10434-023-13119-w</doi></cross_references></HashMap>